Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × OTHER × Agnosia × Clear all

Phase

Phase NA 147 Phase 4 21 Phase 3 17 Phase 2 13 Phase 2/3 5 Phase 1/2 3 Phase 1 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 160 Neoplasms 93 Prostatic Neoplasms 85 Glioblastoma 74 Pancreatic Neoplasms 63 Multiple Myeloma 63 Glioma 61 Brain Neoplasms 56 Lung Neoplasms 46 Head and Neck Neoplasms 43 Melanoma 42 Carcinoma, Hepatocellular 42 Carcinoma, Non-Small-Cell Lung 41 Recurrence 40 Leukemia, Myeloid, Acute 39 Colorectal Neoplasms 38 Squamous Cell Carcinoma of Head and Neck 35 Ovarian Neoplasms 35 Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Neoplasm Metastasis 29 Lymphoma, Non-Hodgkin 29 Lymphoma 28 Carcinoma, Renal Cell 28 Polycystic Ovary Syndrome 27 Stomach Neoplasms 24 Hematologic Neoplasms 23 Sarcoma 21 Endometrial Neoplasms 20 Uterine Cervical Neoplasms 19 Urinary Bladder Neoplasms 19

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03317730 2021-07-20

RAD 1702

University of Alabama at Birmingham

Phase EARLY_PHASE1 Completed

Agnosia, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡